Analysis
Genmab Q4 2025 Earnings Report: Innovation Push Drives Profit Surge
Genmab A/S (Nasdaq: GMAB) released its full-year 2025 financial results, demonstrating the company’s improved operational execution. Total revenue reached $3.72...